Top Biotechnology & Medical Research stocks in United States
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
DNAGinkgo Bioworks Holdings | $1.69bn | n/a | n/a |
GPCRStructure Therapeutics | $1.67bn | n/a | n/a |
SLNOSoleno Therapeutics | $1.63bn | n/a | n/a |
NMRANeumora Therapeutics | $1.55bn | n/a | n/a |
RCUSArcus Biosciences | $1.53bn | n/a | n/a |
MORFMorphic Holding | $1.52bn | n/a | n/a |
DVAXDynavax Technologies | $1.49bn | 168.19 | n/a |
SYRESpyre Therapeutics | $1.49bn | n/a | n/a |
XNCRXencor | $1.46bn | n/a | n/a |
DAWNDay One Biopharmaceuticals | $1.40bn | n/a | n/a |
KNSAKiniksa Pharmaceuticals | $1.40bn | 230.87 | n/a |
AKROAkero Therapeutics | $1.39bn | n/a | n/a |
CGEMCullinan Therapeutics | $1.38bn | n/a | n/a |
FDMT4D Molecular Therapeutics | $1.34bn | n/a | n/a |
PNTPOINT Biopharma Global | $1.33bn | 14.99 | n/a |
VIRVir Biotechnology | $1.32bn | n/a | n/a |
EXAIExscientia | $1.31bn | n/a | n/a |
MNKDMannKind | $1.28bn | 200.6 | n/a |
BCRXBioCryst Pharmaceuticals | $1.27bn | n/a | n/a |
GYREGyre Therapeutics | $1.23bn | n/a | n/a |